Abstract
The appearance of lymph node metastases represents the most important adverse prognostic factor in head and neck squamous cell carcinoma. Therefore, accurate staging of the cervical nodes is crucial in these patients. The management of the clinically and radiologically negative neck in patients with early oral and oropharyngeal squamous cell carcinoma is still controversial, though most centers favor elective neck dissection for staging of the neck and removal of occult disease. As only approximately 30% of patients harbor occult disease in the neck, most of the patients have to undergo elective neck dissection with no benefit. The sentinel node biopsy concept has been adopted from the treatment of melanoma and breast cancer to early oral and oropharyngeal squamous cell carcinoma during the last decade with great success. Multiple validation studies in the context of elective neck dissections revealed sentinel node detection rates above 95% and negative predictive values for negative sentinel nodes of 95%. Sentinel node biopsy has proven its ability to select patients with occult lymphatic disease for elective neck dissection, and to spare the costs and morbidity to patients with negative necks. Many centers meanwhile have abandoned routine elective neck dissection and entered in observational trials. These trials so far were able to confirm the high accuracy of the validation trials with less than 5% of the patients with negative sentinel nodes developing lymph node metastases during observation. In conclusion, sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma can be considered as safe and accurate, with success rates in controlling the neck comparable to elective neck dissection. This concept has the potential to become the new standard of care in the near future.
Similar content being viewed by others
References
Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. New Engl J Med 345(26):1890–1900
Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30
Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Layland MK, Sessions DG, Lenox J (2005) The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 115:629–639
Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB (1993) Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71:452–456
Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds) (1975–2005) SEER Cancer Statistics Review. National Cancer Institute. Bethesda, MD
O’Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM (2000) The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 126(3):360–365
Yuen AP, Lam KY, Chan AC, Wei WI, Lam LK, Ho WK, Ho CM (1999) Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am J Surg 177(1):90–92
Persky MS, Lagmay VM (1999) Treatment of the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 109(7 Pt 1):1160–1164
Alkureishi LW, Ross GL, MacDonald DG, Shoaib T, Gray H, Robertson G, Soutar DS (2007) Sentinel node in head and neck cancer: use of size criterion to upstage the N0 neck in head and neck squamous cell carcinoma. Head Neck 29(2):95–103
Stoeckli SJ, Schuknecht B, Strobel K (2009) Initial staging of the neck in HNSCC: is PET/CT the best? Head Neck (in press)
Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, van der Waal I, Snow GB, Leemans CR (2002) Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 24(3):282–289
van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, Meyer CJ, Snow GB (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177(2):379–384
Ross GL, Soutar DS, MacDonald DG, Shoaib T, Camilleri IG, Robertson AG (2004) Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 11(2):213–218
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
van den Brekel MW, Stel HV, van der Valk P, van der Waal I, Meyer CJ, Snow GB (1992) Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 249(6):349–353
Alex JC, Krag DN (1996) The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 5(1):33–41
Pitman KT, Johnson JT, Edington H, Barnes EL, Day R, Wagner RL, Myers EN (1998) Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 124(7):790–793
Koch WM, Choti MA, Civelek AC, Eisele DW, Saunders JR (1998) Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 124:455–459
Shoaib T, Soutar DS, Prosser JE et al (1999) A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck 21(8):728–733
Werner JA, Dunne AA, Brandt D, Ramaswamy A, Kulkens C, Lippert BM, Folz BJ, Joseph K, Moll R (1999) Studies on significance of sentinel lymphadenectomy in pharyngeal and laryngeal carcinoma. Laryngorhinootologie 78:663–670
Taylor RJ, Wahl RL, Sharma PK, Bradford CR, Terrell JE, Teknos TN, Heard EM, Wolf GT, Chepeha DB (2001) Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 127(8):970–974
Stoeckli SJ, Steinert H, Pfaltz M, Schmid S (2001) Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 125:221–226
Zitsch RP, Todd DW, Renner GJ, Singh A (2000) Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 122:662–666
Bilchik AJ, Giuliano A, Essner R, Bostick P, Kelemen P, Foshag LJ, Sostrin S, Turner RR, Morton DL (1998) Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 4:351–358
Mozzillo N, Chiesa F, Botti G, Caraco C, Lastoria S, Giugliano G, Mazzarol G, Paganelli G, Ionna F (2001) Sentinel node biopsy in head and neck cancer. Ann Surg Oncol 8:103S–105S
Dünne AA, Külkens C, Ramaswamy A, Folz BJ, Brandt D, Lippert BM, Behr T, Moll R, Werner JA (2001) Value of sentinel lymphonodectomy in head and neck cancer patients without evidence of lymphogenic metastatic disease. Auris Nasus Larynx 28(4):339–344
Stoeckli SJ (2007) Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Candidate’s thesis. Laryngoscope 117:1539–1551
Haerle SK, Hany TF, Strobel K, Sidler D, Stoeckli SJ (2009) Is there an additional value of SPECT/CT over lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinoma? Ann Surg Oncol (in press)
Keski-Säntti H, Mätzke S, Kauppinen T, Törnwall J, Atula T (2006) Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 263(11):1008–1012
Bilde A, Von Buchwald C, Mortensen J et al (2006) The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer. Acta Otolaryngol 126(10):1096–1103
Ambrosch P, Brinck U (1996) Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology 10:1221–1226
Stoeckli SJ, Pfaltz M, Ross GL, Steiner HC, MacDonald DG, Wittekind C, Soutar D (2005) The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol 12:919–924
Hermanek P, Hutter RV, Sobin LH, Wittekind C (1999) International Union against cancer classification of isolated tumor cells and micrometastasis. Cancer 86(12):2668–2673
Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
Stoeckli SJ, Pfaltz M, Steinert H, Schmid S (2002) Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope 112(1):111–115
Atula T, Hunter KD, Cooper LA, Shoaib T, Ross GL, Soutar DS (2009) Micrometastases and isolated tumour cells in sentinel lymph nodes in oral and oropharyngeal squamous cell carcinoma. Eur J Surg Oncol (in press)
Terada A, Hasegawa Y, Goto M, Sato E, Hyodo I, Ogawa T, Nakashima T, Yatabe Y (2005) Sentinel lymph node radiolocalization in clinically negative neck oral cancer. Head Neck 28:114–120
Tschopp L, Nuyens M, Stauffer E, Krause T, Zbären P (2005) The value of frozen section analysis of the sentinel lymph node in clinically N0 squamous cell carcinoma of the oral cavity and oropharynx. Otolaryngol Head Neck Surg 132:99–102
Werner JA, Dünne AA, Ramaswamy A, Dalchow C, Behr T, Moll R, Folz BJ, Davis RK (2004) The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck? Head Neck 26(7):603–611
Alkureishi LWT, Ross GL, Shoaib T, Sorensen J, Alvarez J, Poli T, Kovacs A, Alberti F, Soutar DS (2008) Sentinel node biopsy in oral/oropharyngeal squamous cell cancer: five year follow-up. Presented at the annual meeting of the American Head and Neck Society (AHNS), San Francisco, July 2008
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stoeckli, S.J., Alkureishi, L.W.T. & Ross, G.L. Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 266, 787–793 (2009). https://doi.org/10.1007/s00405-009-0955-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-009-0955-2